ViroPharma

WCG expands London office

The agency now serves the international communications needs of many multi-national companies, including Pfizer, Boston Scientific, Dendreon, Genomic Health and ViroPharma.

EMA considers two epilepsy treatments

The European Medicines Agency has accepted for review the marketing authorisation application for Eisai's perampanel while the agency's CHMP has recommended the approval of ViroPharma's Buccolam. ... Meanwhile the Committee for Medicinal Products for

EC gives ViroPharma Cinryze go-ahead

The European Commission has granted ViroPharma Centralised Marketing Authorisation for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema. ... The European Commission has granted ViroPharma Centralised Marketing

Optimer antibiotic approved

difficile-associated diarrhoea.". In clinical trials, Dificid worked as well as ViroPharma's Vancocin (vancomycin) in curing CDAD and was better than vancomycin at preventing recurrence of infection.

FDA reviewers support Optimer antibiotic

In the documents, which are intended to help guide the advisory panel members, the FDA staff reviewers said fidaxomicin worked as well as ViroPharma's Vancocin (vancomycin) in curing C.

[ Previous 5 results ] 2 3 4 5 6 7 [ Next 5 results ]